ArticleESMO gastrointestinal oncology2025

Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer.

H F Kennecke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.